ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

ABN AMRO INVESTMENT SOLUTIONS's Holding History (CIK: 0002080520)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 200,000 Value ($000) $260 Avg Close Range
Q1 2025
Shares 200,000 Value ($000) $231 Avg Close Range
Q4 2024
Shares 400,000 Value ($000) $427 Avg Close Range
Q3 2024
Shares 400,000 Value ($000) $469 Avg Close Range
Q2 2024
Shares 400,000 Value ($000) $432 Avg Close Range
Q1 2024
Shares 500,000 Value ($000) $472 Avg Close Range
Q4 2023
Shares 500,000 Value ($000) $494 Avg Close Range